Tagged: News event

Uber 0

Coverage: The latest on Uber

A lot of ink has been used writing about Uber, the ride-sharing program that has swept the U.S. It seems that everyone has to comment on whether it’s going to work and if the...

Merck 0

Coverage: The pharma deals continue

Merck is spending $3.85 billion, paying a price per share triple what investors think it’s worth, on liver drug maker Idenix. It’s a bold move to gain share of this market. Peter Loftus wrote...